Cargando…
Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis
There have been significant collaborative efforts over the past three years to develop therapies against COVID-19. During this journey, there has also been a lot of focus on understanding at-risk groups of patients who either have pre-existing conditions or have developed concomitant health conditio...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204512/ https://www.ncbi.nlm.nih.gov/pubmed/37218751 http://dx.doi.org/10.3390/biotech12020034 |